Prospects of in the Treatment of Human Viral Infections: A Comprehensive and a Systematic Review

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Nov 18

PMID 39553635

Authors

Masooma

Ariba Qaiser

Dr Sajid Ali

Dr Sobia Manzoor

Affiliations

Soon will be listed here.

Abstract

Background: Viruses cause various human diseases, some of which become pandemic outbreaks lack effective treatments and vaccines. This study gathered data on Carica papaya's antiviral effects against various human viruses, highlighting its potential as a natural treatment. Through , , and clinical study analysis, we illustrated the potential of Carica papaya in combating viral infections and its potential role in cure of common viral diseases.

Method: ology: Research papers on antiviral activity of Carica papaya were identified by using specific keywords in PUBMED, Google Scholar, and ScienceDirect databases. Articles published between January 2015 and March 2024 were screened for inclusion. Eligible studies utilized Carica papaya leaves (powder or juice) or fruits to investigate their effects against human viral infections. Each selected study applied either qualitative or quantitative antiviral assays to assess the efficacy of Carica papaya in combating human viruses.

Results: Fifteen studies went through assessment for antiviral properties of Carica papaya, 7 (46.67 %) of them displayed significant activity against the dengue virus, while 1 study (6.67 %) demonstrated moderate/less effectiveness against dengue serotype-2. Two studies (13.33 %) found no anti-dengue effects. Additionally, Carica papaya exhibited strong antiviral activity against SARS-CoV-2 in 2 studies (13.33 %). One study (6.67 %) showed inhibition of both dengue serotype-2 and chikungunya, and 1 study (6.67 %) each demonstrated inhibitory effects against human immunodeficiency virus and Zika virus infections.

Conclusion: The present study listed human diseases for which Carica papaya revealed significant antiviral effects against Dengue virus, Severe acute respiratory syndrome, Human immunodeficiency virus-I, Chikungunya virus and Zika virus suggesting its potential as a treatment candidate for all these viruses. However, the majority of the research involved screening, with minimal and clinical testing. Further studies and clinical trials should be conducted to explore the potential of Carica papaya in the treatment of human viral infections.

Citing Articles

Phytomedical Properties of for Boosting Human Immunity Against Viral Infections.

Srivastava R, Jaiswal N, Kharkwal H, Dubey N, Srivastava R Viruses. 2025; 17(2).

PMID: 40007026 PMC: 11861161. DOI: 10.3390/v17020271.

In Vitro Determination of Antimicrobial, Antioxidant and Antiviral Properties of Greek Plant Extracts.

Tsakni A, Kyriakopoulou E, Letsiou S, Halvatsiotis P, Rigopoulos H, Vassilaki N Microorganisms. 2025; 13(1).

PMID: 39858945 PMC: 11767790. DOI: 10.3390/microorganisms13010177.

References

Salehi B, Anil Kumar N, Sener B, Sharifi-Rad M, Kilic M, Mahady G . Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus. Int J Mol Sci. 2018; 19(5). PMC: 5983620. DOI: 10.3390/ijms19051459. View

Sathyapalan D, Padmanabhan A, Moni M, P-Prabhu B, Prasanna P, Balachandran S . Efficacy & safety of Carica papaya leaf extract (CPLE) in severe thrombocytopenia (≤30,000/μl) in adult dengue - Results of a pilot study. PLoS One. 2020; 15(2):e0228699. PMC: 7029881. DOI: 10.1371/journal.pone.0228699. View

Adel A, Elnaggar M, Albohy A, Elrashedy A, Mostafa A, Kutkat O . Evaluation of antiviral activity of leaves against SARS-CoV-2 assisted by metabolomic profiling. RSC Adv. 2022; 12(51):32844-32852. PMC: 9667237. DOI: 10.1039/d2ra04600h. View

Abad M, Guerra J, Bermejo P, IRURZUN A, Carrasco L . Search for antiviral activity in higher plant extracts. Phytother Res. 2000; 14(8):604-7. DOI: 10.1002/1099-1573(200012)14:8<604::aid-ptr678>3.0.co;2-l. View

Haddad J, Carcauzon V, El Kalamouni O, Despres P, Garcia C, Remize F . Papaya Fruit Pulp and Resulting Lactic Fermented Pulp Exert Antiviral Activity against Zika Virus. Microorganisms. 2020; 8(9). PMC: 7565477. DOI: 10.3390/microorganisms8091257. View

Patil P, Alagarasu K, Chowdhury D, Kakade M, Cherian S, Yadav J . antiviral activity of formulations against dengue virus type 2 and chikungunya viruses. Heliyon. 2022; 8(12):e11879. PMC: 9723942. DOI: 10.1016/j.heliyon.2022.e11879. View

Jadaun P, Shah P, Harshithkumar R, Said M, Bhoite S, Bokuri S . Antiviral and ROS scavenging potential of Carica papaya Linn and Psidium guajava leaves extract against HIV-1 infection. BMC Complement Med Ther. 2023; 23(1):82. PMC: 10024014. DOI: 10.1186/s12906-023-03916-x. View

Alayli F, Scholle F . Dengue virus NS1 enhances viral replication and pro-inflammatory cytokine production in human dendritic cells. Virology. 2016; 496:227-236. PMC: 4969143. DOI: 10.1016/j.virol.2016.06.008. View

Mattio L, Catinella G, Pinto A, Dallavalle S . Natural and nature-inspired stilbenoids as antiviral agents. Eur J Med Chem. 2020; 202:112541. PMC: 7335248. DOI: 10.1016/j.ejmech.2020.112541. View

10.

Abd Razak M, Mohmad Misnan N, Md Jelas N, Norahmad N, Muhammad A, Ho T . The effect of freeze-dried Carica papaya leaf juice treatment on NS1 and viremia levels in dengue fever mice model. BMC Complement Altern Med. 2018; 18(1):320. PMC: 6282281. DOI: 10.1186/s12906-018-2390-7. View

11.

Senthilvel P, Lavanya P, Kumar K, Swetha R, Anitha P, Bag S . Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents Dengue 2 viral assembly. Bioinformation. 2013; 9(18):889-95. PMC: 3842573. DOI: 10.6026/97320630009889. View

12.

Ghaffarilaleh V, Fisher D, Henkel R . Carica papaya seed extract slows human sperm. J Ethnopharmacol. 2019; 241:111972. DOI: 10.1016/j.jep.2019.111972. View

13.

Norahmad N, Abd Razak M, Mohmad Misnan N, Md Jelas N, Sastu U, Muhammad A . Effect of freeze-dried Carica papaya leaf juice on inflammatory cytokines production during dengue virus infection in AG129 mice. BMC Complement Altern Med. 2019; 19(1):44. PMC: 6371484. DOI: 10.1186/s12906-019-2438-3. View

14.

Sharma N, Mishra K, Chanda S, Bhardwaj V, Tanwar H, Ganju L . Evaluation of anti-dengue activity of Carica papaya aqueous leaf extract and its role in platelet augmentation. Arch Virol. 2019; 164(4):1095-1110. DOI: 10.1007/s00705-019-04179-z. View

15.

Jayasinghe C, Gunasekera D, De Silva N, Jayawardena K, Udagama P . Mature leaf concentrate of Sri Lankan wild type Carica papaya Linn. modulates nonfunctional and functional immune responses of rats. BMC Complement Altern Med. 2017; 17(1):230. PMC: 5406937. DOI: 10.1186/s12906-017-1742-z. View

16.

Keramagi A, Skariyachan S . Prediction of binding potential of natural leads against the prioritized drug targets of chikungunya and dengue viruses by computational screening. 3 Biotech. 2018; 8(6):274. PMC: 5971020. DOI: 10.1007/s13205-018-1303-2. View

17.

Shyr Z, Cheng Y, Lo D, Zheng W . Drug combination therapy for emerging viral diseases. Drug Discov Today. 2021; 26(10):2367-2376. PMC: 8139175. DOI: 10.1016/j.drudis.2021.05.008. View

18.

Banjan B, Krishnan D, Koshy A, Soman S, Leelamma A, Raju R . screening and identification of potential drug-like compounds for dengue-associated thrombocytopenia from leaf extracts. J Biomol Struct Dyn. 2023; 42(11):5963-5981. DOI: 10.1080/07391102.2023.2230293. View

19.

Adhikari B, Marasini B, Rayamajhee B, Bhattarai B, Lamichhane G, Khadayat K . Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review. Phytother Res. 2020; 35(3):1298-1312. PMC: 7675695. DOI: 10.1002/ptr.6893. View

20.

Haggag E, Elshamy A, Rabeh M, Gabr N, Salem M, Youssif K . Antiviral potential of green synthesized silver nanoparticles of and . Int J Nanomedicine. 2019; 14:6217-6229. PMC: 6690046. DOI: 10.2147/IJN.S214171. View